MAPT and Alzheimer disease: It has also been demonstrated that age-related processes, such as neddylation inhibition, synergize with AD-related gene mutations to evoke late-onset AD phenotypes, like Tau pathology [122]; these studies provide an explanation for the late onset that characterizes many of these NDs, despite the presence of inborn mutations.